Skip to main content

Oisin Biotechnologies

Seattle, United States

Oisin Biotechnologies is a drug development company focused on mitigating the senolytic technology to combat age-related diseases.

$10.0M raised
Aug 2025
Series A

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Oisin Biotechnologies

How much funding has Oisin Biotechnologies raised?
Oisin Biotechnologies has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in August 2025.
Who are Oisin Biotechnologies's investors?
Oisin Biotechnologies's investors include AbbVie, Avant Global LLC, Healthspan Capital, Hedgewood, Kingsley Advani.
Where is Oisin Biotechnologies headquartered?
Oisin Biotechnologies is headquartered in Seattle, United States.
What does Oisin Biotechnologies do?
Oisin Biotechnologies is a drug development company focused on mitigating the senolytic technology to combat age-related diseases.
What stage is Oisin Biotechnologies at?
Oisin Biotechnologies is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Oisin Biotechnologies — Funding & Investors." VCBacked, August 1, 2025, https://www.vcbacked.co/company/oisin-biotechnologies. Accessed July 4, 2026.
APA
VCBacked. (2025). Oisin Biotechnologies — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/oisin-biotechnologies
Wikipedia (cite web)
{{cite web |title=Oisin Biotechnologies — Funding & Investors |url=https://www.vcbacked.co/company/oisin-biotechnologies |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .